Clinical Trials List
Protocol NumberTAI-201
Active
2021-06-01 - 2025-06-30
Phase I
Recruiting3
-
Trial Applicant
Efficient Pharma Management Corp.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Chien-Chung Lin Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Po-Lan Su Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Chang Liu Division of Hematology & Oncology
- Hui-Hua Hsiao Division of Hematology & Oncology
- 高育青 Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張平穎 Division of Hematology & Oncology
- 吳宜穎 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- 何景良 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30-40 participants
-
Global
30-40 participants
